Adeshwar Meditex Ltd Stock Price Today (NSE: ADESHWAR)
Adeshwar Meditex Ltd
Fundamental Score
Adeshwar Meditex Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Adeshwar Meditex Ltd share price today is ₹15.00, down 6.54% on NSE/BSE as of 17 June 2026. Adeshwar Meditex Ltd (ADESHWAR) is a Small-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹25.54 (Cr). The 52-week high for ADESHWAR share price is ₹21.80 and the 52-week low is ₹13.30. At a P/E ratio of 12.34x, ADESHWAR is currently trading below its industry average P/E of 45.95x. The company has a Return on Equity (ROE) of 5.51% and a debt-to-equity ratio of 0.16.
Adeshwar Meditex Ltd Share Price Chart — NSE/BSE Historical Performance
Adeshwar Meditex Ltd share price chart: 19.16% return over the past month. 52-week high ₹21.80, 52-week low ₹13.30.
Adeshwar Meditex Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹18.41 | ₹18.41 | ₹18.41 | ₹18.41 | 0.00 (Cr) | |
| ₹18.41 | ₹18.41 | ₹18.41 | ₹18.41 | 0.00 (Cr) | |
| ₹14.95 | ₹18.98 | ₹14.95 | ₹18.41 | 18.00K (Cr) | |
| ₹17.55 | ₹17.55 | ₹17.55 | ₹17.55 | 0.00 (Cr) | |
| ₹17.55 | ₹17.55 | ₹17.55 | ₹17.55 | 0.00 (Cr) | |
| ₹17.55 | ₹17.55 | ₹17.55 | ₹17.55 | 0.00 (Cr) | |
| ₹17.55 | ₹17.55 | ₹17.55 | ₹17.55 | 0.00 (Cr) | |
| ₹13.50 | ₹17.55 | ₹13.50 | ₹17.55 | 18.00K (Cr) | |
| ₹16.43 | ₹16.43 | ₹16.43 | ₹16.43 | 0.00 (Cr) | |
| ₹16.43 | ₹16.43 | ₹16.43 | ₹16.43 | 0.00 (Cr) |
Adeshwar Meditex Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹18.41 | ₹18.41 | ₹18.41 | ₹18.41 | +0.00% | |
| ₹15.45 | ₹18.98 | ₹13.50 | ₹18.41 | +19.16% | |
| ₹16.98 | ₹18.99 | ₹13.75 | ₹15.45 | -9.01% | |
| ₹18.00 | ₹18.40 | ₹14.25 | ₹16.98 | -5.67% | |
| ₹18.75 | ₹18.75 | ₹18.75 | ₹18.75 | +0.00% | |
| ₹16.00 | ₹21.00 | ₹13.30 | ₹18.75 | +17.19% | |
| ₹17.70 | ₹17.95 | ₹13.95 | ₹16.00 | -9.60% | |
| ₹18.50 | ₹19.24 | ₹15.52 | ₹17.70 | -4.32% | |
| ₹15.16 | ₹21.80 | ₹15.16 | ₹18.50 | +22.03% | |
| ₹15.76 | ₹19.49 | ₹15.15 | ₹17.25 | +9.45% | |
| ₹18.00 | ₹21.59 | ₹15.60 | ₹18.34 | +1.89% | |
| ₹18.00 | ₹18.00 | ₹16.05 | ₹18.00 | +0.00% |
AI Research Briefing
Powered by Gemini · 2026-04-22
Adeshwar Meditex is a micro-cap lottery ticket with a high probability of ending up worthless.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Recent news primarily consists of regulatory filings related to SEBI's (Substantial Acquisition of Shares and Takeover) Regulations, 2011. These filings pertain to disclosures from promoters regarding their shareholding and confirmation of no encumbrance on shares for FY26.
CORE STORY (THE REAL GAME)
Adeshwar Meditex is being priced as a beneficiary of the growing, but highly competitive, Indian wound care and medical disposables market. The real game is whether they can scale and maintain profitability in a sector dominated by larger players.
- Industry tailwinds in healthcare analytics and medical disposables
- Apparent undervaluation based on P/E ratio
- Stable promoter holding
- Significant order wins
- Turnaround in quarterly sales and profit growth
- Improved free cash flow generation
- Micro-cap with low trading volume and liquidity risk
- Declining YoY profit and sales
- Negative EPS CAGR over 5 years
No FII/DII activity. Promoter holding stable.
Indian healthcare sector benefits from government initiatives and increasing healthcare expenditure.
No major news found after live search.
Profit not consistently converting to cash. Free Cash Flow 5Y: ₹11.06 Cr.
In the next 3-6 months, Adeshwar needs to demonstrate a turnaround in sales and profit growth to justify its valuation. Without it, the stock is likely to underperform.
Primary Thesis Risk
Illiquidity and weak financials can lead to a complete wipeout.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Adeshwar Meditex Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Adeshwar Meditex Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ADESHWAR across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 12.34 vs Industry: 45.95)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.16)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (5.25x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (57.55%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (5.51%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.27%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-18.89%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-26.50%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-19.37% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-1.36% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Adeshwar Meditex Ltd vs Healthcare Research, Analytics & Technology Peers
Peer Comparison - Healthcare Research, Analytics & Technology
Compare Adeshwar Meditex Ltd with 8 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Adeshwar Meditex LtdAdeshwar Medite...Selected✓ ADESHWAR • 543309 | 29.2/100 | ₹15.00₹15 | ₹25.54₹25.54 | 12.34Average 12.3 Average | 5.51%Poor 5.51% Poor | 8.27%Poor 8.27% Poor | 0.16Excellent 0.2 Excellent | -1.36%Poor -1.36% Poor | 8.33%Good 8.33% Good | 0.00% |
Syngene International LtdSyngene Interna... SYNGENE • 539268 | 41.6/100 | ₹460.40₹460 | ₹25985.68₹25985.68 | 55.50Average 55.5 Average | 10.53%Average 10.53% Average | 13.52%Average 13.52% Average | 0.12Excellent 0.1 Excellent | 5.71%Good 5.71% Good | 12.60%Good 12.60% Good | 0.19% |
Indegene LtdIndegene Ltd... INDGN • 544172 | 66.8/100 | ₹518.90₹519 | ₹12660.10₹12660.10 | 28.40Average 28.4 Average | 20.59%Excellent 20.59% Excellent | 24.80%Excellent 24.80% Excellent | 0.04Excellent 0.0 Excellent | 67.93%Excellent 67.93% Excellent | 34.59%Excellent 34.59% Excellent | 0.38% |
Suven Life Sciences LtdSuven Life Scie... SUVEN • 530239 | 6.5/100 | ₹267.15₹267 | ₹3927.58₹3927.58 | — — | -87.22%Poor -87.22% Poor | -86.96%Poor -86.96% Poor | 0.00Excellent 0.0 Excellent | -24.19%Poor -24.19% Poor | -12.00%Poor -12.00% Poor | 0.00% |
Vimta Labs LtdVimta Labs Ltd... VIMTALABS • 524394 | 65.8/100 | ₹456.70₹457 | ₹2716.50₹2716.50 | 36.39Average 36.4 Average | 19.43%Good 19.43% Good | 25.22%Excellent 25.22% Excellent | 0.02Excellent 0.0 Excellent | 58.03%Excellent 58.03% Excellent | 13.74%Good 13.74% Good | 0.16% |
Take Solutions LtdTake Solutions ... TAKE • 532890 | 19.5/100 | ₹30.93₹31 | ₹481.24₹481.24 | 120.61Average 120.6 Average | 644.12%Excellent 644.12% Excellent | 11.24%Average 11.24% Average | 0.00Excellent 0.0 Excellent | 38.14%Excellent 38.14% Excellent | — — | 0.00% |
Bilcare LtdBilcare Ltd... BI • 526853 | 6.9/100 | ₹62.20₹62 | ₹200.42₹200.42 | — — | -5.58%Poor -5.58% Poor | 1.10%Poor 1.10% Poor | 1.48Average 1.5 Average | 13.81%Good 13.81% Good | -15.48%Poor -15.48% Poor | 0.00% |
NOVELIX PHARMACEUTICALS LIMITENOVELIX PHARMAC... NOVELIX • 536565 | 40.6/100 | ₹57.14₹57 | ₹101.70₹101.70 | 104.85Average 104.8 Average | 0.64%Poor 0.64% Poor | 0.96%Poor 0.96% Poor | 0.00Excellent 0.0 Excellent | -2.33%Poor -2.33% Poor | 82.92%Excellent 82.92% Excellent | 0.00% |
Vanta Bioscience LtdVanta Bioscienc... VANTABIO • 540729 | 7.2/100 | ₹24.45₹24 | ₹16.84₹16.84 | — — | -37.24%Poor -37.24% Poor | -11.58%Poor -11.58% Poor | 1.59Average 1.6 Average | — — | -32.27%Poor -32.27% Poor | 0.00% |
Top Healthcare Research, Analytics & Technology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Syngene International Ltd share price25985.68 Cr
- Indegene Ltd share price12660.10 Cr
- Suven Life Sciences Ltd share price3927.58 Cr
- Vimta Labs Ltd share price2716.50 Cr
- Take Solutions Ltd share price481.24 Cr
Adeshwar Meditex Ltd PE Ratio History
Historical price-to-earnings ratio for ADESHWAR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹1.39 | ₹26.00 | 18.7x |
| FY 2023 | ₹1.44 | ₹32.00 | 22.2x |
| FY 2022 | ₹0.55 | ₹28.00 | 50.9x |
| FY 2021 | ₹1.16 | ₹38.55 | 33.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Adeshwar Meditex Ltd Quarterly Performance
Latest quarterly metrics for ADESHWAR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-26.50%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-18.89%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
8.33%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-1.36%
Compounded annual net profit growth over 5 years
Adeshwar Meditex Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ADESHWAR — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Adeshwar Meditex Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Adeshwar Meditex Ltd (ADESHWAR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Adeshwar Meditex Ltd
About ADESHWAR (Adeshwar Meditex Ltd)
Adeshwar Meditex Ltd is a pioneering force in the healthcare landscape, specializing in the research, analytics, and technological advancements surrounding advanced wound care and ...infection control. The company dedicates itself to understanding the intricate biological processes involved in wound healing, leveraging data-driven insights to create innovative solutions that promote faster recovery and minimize patient discomfort. Adeshwar's research division delves into the complexities of microbial resistance and the efficacy of various therapeutic agents, constantly seeking to improve the performance and safety of its product portfolio. By integrating cutting-edge technology with a deep understanding of clinical needs, Adeshwar strives to redefine the standards of wound management, empowering healthcare professionals with effective tools to deliver optimal patient outcomes. The heart of Adeshwar Meditex lies in its commitment to developing next-generation wound care solutions. They achieve this by integrating advanced biomaterials with sophisticated drug delivery systems. This approach allows for precise control over the healing process, tailoring treatments to individual patient needs. The company's analytical capabilities allow them to evaluate the effectiveness of these solutions. This includes assessing their impact on infection rates, scar formation, and overall healing time. Their team of scientists and engineers works tirelessly to translate groundbreaking research into practical applications, fostering a continuous cycle of innovation that addresses the evolving challenges of wound care. Adeshwar Meditex's technological prowess extends beyond product development. It encompasses a comprehensive suite of digital tools designed to enhance the patient experience and improve healthcare delivery. The company is actively exploring the use of artificial intelligence and machine learning to personalize wound care plans, predict potential complications, and optimize treatment protocols. Additionally, Adeshwar is committed to fostering collaboration and knowledge sharing within the healthcare community. This is achieved by providing healthcare professionals with access to valuable data and insights. Ultimately, Adeshwar seeks to be a catalyst for positive change in the world of wound care and infection control.
Company Details
Key Leadership
ADESHWAR Share Price: Frequently Asked Questions
What is the current share price of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd (ADESHWAR) trades at ₹15.00 on NSE and BSE. Market cap ₹25.54 (Cr). Educational data only.
What is the P/E ratio of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has a P/E of 12.34x vs industry average 45.95x.
What is the Bull Run score for Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has a Bull Run score of 29.2/100 based on 25+ financial parameters.
Does Adeshwar Meditex Ltd pay dividends?
Adeshwar Meditex Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has ROE of 5.51%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has debt-to-equity of 0.16.
Is Adeshwar Meditex Ltd a good investment?
Bull Run gives Adeshwar Meditex Ltd a score of 29.2/100. This is not investment advice — consult a SEBI-registered advisor.